Compare KRYS & SPXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KRYS | SPXC |
|---|---|---|
| Founded | 2015 | 1912 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2B | 9.7B |
| IPO Year | 2017 | 1994 |
| Metric | KRYS | SPXC |
|---|---|---|
| Price | $305.25 | $150.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 14 |
| Target Price | ★ $388.22 | $236.77 |
| AVG Volume (30 Days) | 296.5K | ★ 713.9K |
| Earning Date | 11-02-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 128.00 | 18.08 |
| EPS | ★ 5.66 | 4.35 |
| Revenue | $389,130,000.00 | ★ $2,265,100,000.00 |
| Revenue This Year | $27.84 | $22.67 |
| Revenue Next Year | $27.62 | $15.88 |
| P/E Ratio | $54.71 | ★ $35.30 |
| Revenue Growth | ★ 33.94 | 14.17 |
| 52 Week Low | $198.02 | $137.86 |
| 52 Week High | $382.54 | $251.08 |
| Indicator | KRYS | SPXC |
|---|---|---|
| Relative Strength Index (RSI) | 43.87 | 40.30 |
| Support Level | $284.16 | $137.86 |
| Resistance Level | $317.53 | $180.49 |
| Average True Range (ATR) | 11.47 | 7.27 |
| MACD | 0.01 | -0.17 |
| Stochastic Oscillator | 49.77 | 43.03 |
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.
SPX Technologies Inc supplies engineered heating, ventilation, and air conditioning, or HVAC, products, as well as detection and measurement technologies and power equipment. The company operates through two reportable segments. The HVAC segment which generates the majority of the revenue for the company, designs, manufactures, installs, and services cooling products, as well as heating and ventilation products. The Detection and Measurement technologies segment designs, manufactures, and installs underground pipe and cable locators and inspection equipment, bus-fare collection systems, and others. Geographically, the company has its operations in the United States, Canada, China, the United Kingdom, and Others. It derives maximum revenue from United States.